The Therapeutic Advances In Rare Disease is a research journal that publishes research in the field of rare diseases, genetics, clinical medicine, clinical and molecular aspects of rare diseases, medicine. This journal is published by the SAGE Publishing. The ISSN of this journal is .
Also, please check the following important details about therapeutic advances in rare disease: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.
According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.
The ISSN (International Standard Serial Number) is an 8-digit code used to uniquely identify journals. ISSN numbers are assigned by a network of ISSN National Centres, usually located at national libraries and coordinated by the ISSN International Centre based in Paris. The International Centre is an intergovernmental organization created in 1974 through an agreement between UNESCO and the French government.
Journal Title: | Therapeutic Advances in Rare Disease |
Publisher: | SAGE Publishing |
P-ISSN: | |
E-ISSN: | 2633-0040 |
Language: | English |
Country of Publisher: | United Kingdom |
APC: | No |
Processing Time (Weeks): | 15 |
Review Process: | Anonymous peer review |
Subjects: | Medicine: Internal medicine |
The therapeutic advances in rare disease is indexed in:
An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.
The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).
Based on the Official Journal Homepage, the therapeutic advances in rare disease does not charge any publication fee.
An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.
The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the therapeutic advances in rare disease publishes research articles in 15 weeks on an average.
Visit to the official website of the journal/ conference to check the details about call for papers.
If your research is related to rare diseases, genetics, clinical medicine, clinical and molecular aspects of rare diseases, medicine, then visit the official website of therapeutic advances in rare disease and send your manuscript.
SIMILIAR JOURNALS
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY D-GENOMICS & PROTEOMICS
ISSN: 1744-117XEUROPEAN JOURNAL OF HUMAN GENETICS
ISSN: 1018-4813TOP RESEARCH JOURNALS